Negative Results When Immunotherapy Was Added Onto Radiation Negative Results When Immunotherapy Was Added Onto Radiation
A phase 3 trial investigating the addition of immunotherapy to avelumab onto chemoradiotherapy in patients with head and neck cancer was stopped early.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 9, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

VEXAS: A Novel Rheumatologic, Hematologic Syndrome VEXAS: A Novel Rheumatologic, Hematologic Syndrome
Older men with a novel adult-onset, severe autoinflammatory syndrome known by the acronym VEXAS are likely hiding in plain sight in many adult rheumatology, hematology, and dermatology practices.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 9, 2021 Category: Dermatology Tags: Rheumatology News Source Type: news

Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine Low-Risk Thyroid Cancer: No Benefit of Postsurgical Iodine
Forgoing postoperative radioactive iodine in low-risk differentiated thyroid cancer is supported by phase 3 data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

After 24 Years, Doc Fired by Hospital. Local Uproar Followed. After 24 Years, Doc Fired by Hospital. Local Uproar Followed.
Tom Weiner, MD, has received tremendous support from locals and is fighting back with a lawsuit after being fired from his post for allegedly causing patient harm.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Morning (vs Evening) Dosing and Better Survival in Glioblastoma Morning (vs Evening) Dosing and Better Survival in Glioblastoma
Taking temozolomide in the morning, rather than the evening, was associated with improved survival in some patients with newly diagnosed glioblastoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 8, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Screening Stopped by Pandemic: Repercussions to Come? Cancer Screening Stopped by Pandemic: Repercussions to Come?
Most healthcare systems stopped screening when the global pandemic hit. Will this lead to more advanced cancers and higher mortality for years to come?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 7, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Low-Calorie Diet Linked to Improved Chemo Response in Leukemia Low-Calorie Diet Linked to Improved Chemo Response in Leukemia
A low-sugar/low-carb diet and exercise regimen was associated with an improved response to chemotherapy in a pilot study in children and adolescents with leukemia.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cancer Diagnoses Jump at 65 Years When Medicare Kicks In Cancer Diagnoses Jump at 65 Years When Medicare Kicks In
An abrupt jump in cancer diagnoses at the age of 65 in the US suggests that people are not seeking medical care until they are eligible for Medicare health insurance.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA approves new dosing regimen for cetuximab
Hematology / Oncology News Burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 7, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Bariatric Surgery May Cut Cancer in Obesity With Liver Disease Bariatric Surgery May Cut Cancer in Obesity With Liver Disease
Among working adults with severe obesity and fatty liver disease, rates of cancer were lower for those who had bariatric surgery, especially those with obesity-related cancer, during a 10-month median follow-up.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Technique Combines'Best of Both Worlds' to Target Lung Nodules Technique Combines'Best of Both Worlds' to Target Lung Nodules
Dr Chan explained that microwave ablation of lung nodules is faster and produces larger ablation zones, compared with radiofrequency ablation.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 7, 2021 Category: Cancer & Oncology Tags: Pulmonary Medicine News Source Type: news

Despite COVID, Americans Still Help Others With Medical Bills Despite COVID, Americans Still Help Others With Medical Bills
Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 6, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Study IDs 3 COVID-19 Phenotypes, Could Help Guide Care Study IDs 3 COVID-19 Phenotypes, Could Help Guide Care
One phenotype was linked with 7 times the risk of dying compared with the phenotype with the best outcomes. The data could eventually guide patient care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 5, 2021 Category: Cancer & Oncology Tags: Infectious Diseases News Source Type: news

Liver Transplant Emerges for Hepatic Mets in Colorectal Cancer Liver Transplant Emerges for Hepatic Mets in Colorectal Cancer
A new indication for a scarce resource?Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 5, 2021 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Chronic Immune-Related Adverse Events Likely Common After Anti-PD-1 Therapy for Melanoma Chronic Immune-Related Adverse Events Likely Common After Anti-PD-1 Therapy for Melanoma
Chronic immune-related adverse events associated with Anti-PD-1 therapy for melanoma were more common than previously thought in a retrospective multicenter study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 2, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Starting Monday, Patients Can Read Your Notes: 5 Key Things Starting Monday, Patients Can Read Your Notes: 5 Key Things
Monday, April 5 is the start of a law requiring healthcare groups to provide patients with immediate electronic access to their doctor's clinical notes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Low-calorie diet and mild exercise improve survival for young people with leukemia
In some cancers, including leukemia in children and adolescents, obesity can negatively affect survival outcomes. Obese young people with leukemia are 50% more likely to relapse after treatment than their lean counterparts.Now,a study led by researchers at UCLA and Children’s Hospital Los Angeles has shown that a combination of modest dietary changes and exercise can dramatically improve survival outcomes for those with acute lymphoblastic leukemia, the most common childhood cancer.The researchers found that patients who reduced their calorie intake by 10% or more and adopted a moderate exercise program imm...
Source: UCLA Newsroom: Health Sciences - April 1, 2021 Category: Universities & Medical Training Source Type: news

FDA approves isatuximab-irfc for multiple myeloma
Hematology / Oncology News (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Risk-Based Mammography Proposed for Times of Reduced Capacity Risk-Based Mammography Proposed for Times of Reduced Capacity
During times when healthcare access may be limited, such as during the COVID-19 pandemic, a risk-based approach can help pinpoint the women who are most likely to benefit from mammogram screening.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 1, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news

Steroids Can Be Stopped in Some Older Myeloma Patients Steroids Can Be Stopped in Some Older Myeloma Patients
In intermediate-fit elderly patients newly diagnosed with multiple myeloma, dexamethasone can be stopped during maintenance without having an adverse effect on outcome.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 1, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Diet and exercise may increase efficacy of chemotherapy for children with cancer
(American Society of Hematology) New research published today in the journal Blood Advances is the first to show that restricting calories, reducing fat and sugar intake, and increasing physical activity may boost the effectiveness of chemotherapy for older children and adolescents with leukemia. This intervention, which improved chemotherapy outcomes for children being treated at two institutions, will be further studied through a national trial later this year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 1, 2021 Category: Cancer & Oncology Source Type: news

Europe Approves Pemigatinib for Bile Duct Cancer Europe Approves Pemigatinib for Bile Duct Cancer
The oral targeted therapy is for the treatment of locally advanced or metastatic cholangiocarcinoma.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Increased Cancer Risk From Night Shift Due to Gene Dysregulation? Increased Cancer Risk From Night Shift Due to Gene Dysregulation?
Working nights appears to disrupt the timing of cancer-related gene expression in a way that reduces the effectiveness of the body's DNA repair processes when they are most needed.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Quality of Life on Cancer Drugs ― Still Largely a Mystery Quality of Life on Cancer Drugs ― Still Largely a Mystery
Despite 30 years of research demonstrating that quality-of-life considerations are crucial for patients with cancer, drug approvals rarely include meaningful data.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Inactivity Drives 1 in 14 Deaths Globally, New Data Suggest Inactivity Drives 1 in 14 Deaths Globally, New Data Suggest
Healthcare providers should stress the necessity of adequate physical activity to their patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2021 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Global Registry Refines COVID-19 Risk in Adult Congenital HD Global Registry Refines COVID-19 Risk in Adult Congenital HD
Although the overall data were reassuring, the analysis confirmed certain subgroups remain at high risk from COVID-19 and warrant early vaccination, experts say.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 31, 2021 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

HOPA Addresses Health Equity Head On with Conference Keynote Entitled...
The Hematology/Oncology Pharmacy Association (HOPA) is honored to welcome Lakesha M. Butler, PharmD, BCPS, Diversity and Inclusion Coordinator at Southern Illinois University Edwardsville (SIUE) to...(PRWeb March 31, 2021)Read the full story at https://www.prweb.com/releases/hopa_addresses_health_equity_head_on_with_conference_keynote_entitled_dismantling_structural_racism_in_pharmacy/prweb17835587.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 31, 2021 Category: Pharmaceuticals Source Type: news

Gynecologic Cancer Pts Risk Insurance Loss,'Catastrophic' Costs Gynecologic Cancer Pts Risk Insurance Loss,'Catastrophic' Costs
Gynecologic cancer patients in the United States have higher rates of insurance loss and"catastrophic" health expenses.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Cytoreduction in Advanced Ovarian Cancer:'Keep the Status Quo'Cytoreduction in Advanced Ovarian Cancer:'Keep the Status Quo '
A retrospective case-control study showed that optimal cytoreductive surgery is an independent predictor of overall survival, even when controlling for response to chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

ctDNA for Progression on Fulvestrant in ER+ Breast Cancer ctDNA for Progression on Fulvestrant in ER+ Breast Cancer
Does ctDNA prove an effective indicator of early progression on fulvestrant therapy in patients with advanced ER+ breast cancer?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Invasive Lobular Carcinoma: The Importance of This Subtype Invasive Lobular Carcinoma: The Importance of This Subtype
Get up-to-date on the latest research that has advanced our understanding of the pathology and management of this common subtype of breast cancer.Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Mayo Clinic Minute: Understanding, treating lymphoma
Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The main two subtypes are Hodgkin lymphoma and non-Hodgkin lymphoma. Because of breakthrough research, this once fatal diagnosis has been transformed into a curable condition. In this Mayo Clinic Minute, Dr. Stephen Ansell, a Mayo Clinic hematologist, discusses the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 30, 2021 Category: Databases & Libraries Source Type: news

Treating Metastatic TNBC: Where Are We Now? Treating Metastatic TNBC: Where Are We Now?
New antibody-drug conjugates are a step in the right direction, but the key to developing effective therapies hinges on identifying the best molecular targets.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news

FDA approves idecabtagene vicleucel for multiple myeloma
Hematology / Oncology News burst (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Has COVID-19 Led to More Advanced Cancers? Has COVID-19 Led to More Advanced Cancers?
Because of lockdowns and a fear of healthcare institutions during COVID-19 surges, many patients have postponed or skipped their regular cancer screenings.Medscape Reader Polls (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

EU Panel Endorses Duvelisib for CLL and Follicular Lymphoma EU Panel Endorses Duvelisib for CLL and Follicular Lymphoma
The panel recommends EU approval for duvelisib (Copiktra) for certain patients with chronic lymphocytic leukemia (CLL) or follicular lymphoma.International Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

First CAR T-Cell Therapy for Multiple Myeloma: Abecma First CAR T-Cell Therapy for Multiple Myeloma: Abecma
Idecabtagene vicleucel is the first chimeric antigen receptor (CAR) T-cell therapy to target B-cell maturation antigen, and the first to be approved for use in multiple myeloma.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 29, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news

Step Therapy: Inside the Fight Against'Fail First' Medicine Step Therapy: Inside the Fight Against'Fail First' Medicine
Doctors and nurses are leading the movement against insurance requirements that force patients to accept medications other than the ones initially prescribed. Where do laws stand now, and what's next?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2021 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis Denosumab Now Dominant Therapy for Cancer-Associated Osteoporosis
In changing patterns of osteoporosis drug prescriptions, denosumab has risen to the top of cancer indications.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2021 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Huge, Struggling Breast Cancer Screening Trial Gets Lifeline Huge, Struggling Breast Cancer Screening Trial Gets Lifeline
A controversial, big-budget breast cancer screening trial got a vote of confidence from a special working group of the NCI.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Allo-HSCT Plus MAb Can Boost Survival in Patients With r/r B-ALL Allo-HSCT Plus MAb Can Boost Survival in Patients With r/r B-ALL
Researchers did a landmark analysis of 110 patients who achieved minimal residual disease-negative status after monoclonal antibody treatment, and looked at results at 2, 4, and 6 months.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 26, 2021 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

Call to Eradicate All Types of HPV Cancers, not Just Cervical Call to Eradicate All Types of HPV Cancers, not Just Cervical
Widespread gender-neutral vaccination against human papilloma virus (HPV) would eliminate HPV infections that cause many different cancer types, not just cervical cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Risk Factors Predict Graft Failure in Pediatric Acute Leukemia Patients Risk Factors Predict Graft Failure in Pediatric Acute Leukemia Patients
Researchers have developed a predictive score for the risk of graft failure in patients with acute leukemia who undergo allogeneic hematopoietic stem cell transplantation with ex vivo T-cell depletion.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

All-Cause and CVD Mortality Among Breast Cancer Survivors All-Cause and CVD Mortality Among Breast Cancer Survivors
A new study finds that breast cancer survivors may be at higher risk for all-cause and CVD-related mortality, which could have important implications for prevention strategies.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Could Tamoxifen Dose Be Slashed Down to 2.5 mg? Could Tamoxifen Dose Be Slashed Down to 2.5 mg?
Adherence to tamoxifen is notoriously low because of troublesome side effects. Could a substantially lower dose be used instead?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 25, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Studies Back Neoadjuvant Strategies for Melanoma Studies Back Neoadjuvant Strategies for Melanoma
Two analyses of neoadjuvant immunotherapy support more rigorous study with RCTs of neoadjuvant vs adjuvant strategies for melanoma, says Dr Weber.Medscape Oncology (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 24, 2021 Category: Surgery Tags: Hematology-Oncology Commentary Source Type: news

Nine Oncologists Sue Medical Center Over Termination Nine Oncologists Sue Medical Center Over Termination
Nine oncologists have filed a lawsuit against a US medical center for terminating their employment and denying them hospital privileges.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Surprise: US Tops Europe for Women Oncologists on Panels Surprise: US Tops Europe for Women Oncologists on Panels
American women oncologists occupy roughly equal proportions of influential clinical practice guideline panels as do men. Not true in Europe.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Community Oncologists Balk at Home Chemo's Financial Effects Community Oncologists Balk at Home Chemo's Financial Effects
At-home cancer treatments are increasingly popular among patients and payers, but financially they pose yet another threat to community oncology practices.Medscape Oncology (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 23, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Poor Survival With COVID in Patients Who Have Had HSCT Poor Survival With COVID in Patients Who Have Had HSCT
Patients who developed COVID-19 within 12 months of receiving a hematopoetic stem cell transplant (HSCT) were especially vulnerable.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 23, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news